Interleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon α on lupus endothelial cell progenitors

Rheumatology (United Kingdom)

Volumn 54, Issue 6, 2015, Pages 1114-1123

  Cates, Alyssa M ^a   Holden, Victoria I ^a   Myers, Emily M ^a   Smith, Carolyne K ^b   Kaplan, Mariana J ^b   Kahlenberg, J Michelle ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Cardiovascular; Endothelial progenitor; IL 10; Interferon ; Lupus

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 10; MATRIGEL; NEUTRALIZING ANTIBODY;

ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR RISK; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84938512496     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu431     Document Type: Article

References (31)

1. Manzi S, Meilahn EN, Rairie JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408-15.
2. Briasoulis A, Tousoulis D, Antoniades C, Papageorgiou N, Stefanadis C. The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development. Cardiovasc Ther 2011;29:125-39.
3. Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-7.
4. Denny MF, Thacker S, Mehta H et al. Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood 2007;110: 2907-15.
5. Thacker SG, Duquaine D, Park J, Kaplan MJ. Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells. Lupus 2010;19: 288-99.
6. Kahlenberg JM, Thacker SG, Berthier CC et al. Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus. J Immunol 2011;187:6143-56.
7. Briasoulis A, Tousoulis D, Antoniades C, Papageorgiou N, Stefanadis C. The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development. Cardiovasc Ther 2011;29:125-39.
8. Schmidt-Lucke C, Rössig L, Fichtlscherer S et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981-7.
9. George J, Herz I, Goldstein E et al. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol 2003;23:e57-60.
10. Thacker S, Berthier CC, Mattinzoli D et al. The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction. J Immunol 2010; 185:4457-69.
11. Thacker SG, Zhao W, Smith CK et al. Type I interferons modulate vascular function, repair, thrombosis and plaque progression in murine models of lupus and atherosclerosis. Arthritis Rheum 2012;64:2975-85.
12. Kahlenberg JM, Yalavarthi S, Zhao W et al. An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage. Arthritis Rheumatol 2014;66: 152-62.
13. Liu P, Song J, Su H et al. IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: a metaanalysis. PLoS One 2013;8:e69547.
14. Koenig KF, Groeschi I, Pesickova SS et al. Serum cytokine profile in patients with active lupus nephritis. Cytokine 2012;60:410-6.
15. Guarda G, Braun M, Staehli F et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 2011;34:213-23.
16. Mallat Z, Besnard S, Duriez M et al. Protective role of interleukin-10 in atherosclerosis. Circulation Res 1999;85: e17-24.
17. Cavusoglu E, Marmur JD, Hojjati MR et al. Plasma interleukin-10. levels and adverse outcomes in acute coronary syndrome. Am J Med 2011;124:724-30.
18. Rodríguez-Carrio J, Prado C, de Paz B et al. Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients. Rheumatology 2012;51:1775-84.
19. Castejon R, Jimenez-Ortiz C, Valero-Gonzalez S et al. Decreased circulating endothelial progenitor cells as an early risk factor of subclinical atherosclerosis in systemic lupus erythematosus. Rheumatology 2014;53: 631-8.
20. Rabquer BJ, Amin MA, Teegala N et al. Junctional adhesion molecule-C Is a soluble mediator of angiogenesis. J Immunol 2010;85:1777-85.
21. Crow MK, Kirou KA. Interferon-alpha in systemic lupus erythematosus. Curr Opin Rheumatol 2004;16:541-7.
22. Zediak VP, Hunter CA. IL-10 fails to inhibit the production of IL-18 in response to inflammatory stimuli. Cytokine 2003;21:84-90.
23. Krishnamurthy P, Thai M, Verma S et al. Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium. Circ Res 2011;109:1280-9.
24. Waibler Z, Anzaghe M, Konur A et al. Excessive CpG 1668 stimulation triggers IL-10 production by cDC that inhibits IFN-alpha responses by pDC. Eur J Immunol 2008;38: 3127-37.
25. Liu B-S, Janssen HLA, Boonstra A. Type I and III interferons enhance IL-10R expression on human monocytes and macrophages, resulting in IL-10-mediated suppression of TLR-induced IL-12. Eur J Immunol 2012;42: 2431-40.
26. + T cell-related gene responses in the autoimmune NZBWF1 mouse. PLoS One 2014;9: e100255.
27. Matsui F, Rhee A, Hile KL, Zhang H, Meldrum KK. IL-18 induces profibrotic renal tubular cell injury via STAT3 activation. Am J Physiol Renal Physiol 2013;305:F1014-21.
28. Ehlting C, Lai WS, Schaper F et al. Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-alpha involves activation of the MKK6/p38MAPK/ MK2 cascade. J Immunol 2007;178:2813-26.
29. Liu Y, Zhu T, Cai G et al. Elevated circulating CD4+ICOS+Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus. Lupus 2011;20: 620-7.
30. Yu SL, Wong CK, Wong PT et al. Down-regulated NOD2 by immunosuppressants in peripheral blood cells in patients with SLE reduces the muramyl dipeptide-induced IL-10 production. PLoS One 2011;6:e23855.
31. Lauwerys BR, Garot N, Renauld JC, Houssiau FA. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients. Arthritis Rheum 2000;43:1976-81.